Standout Papers
Citation Impact
Citing Papers
Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature
2010
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein
2005 StandoutNobel
Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor
2002 StandoutScience
[5]Measurement of oxygen radical absorbance capacity in biological samples
1999
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
Magnetic Resonance Imaging in Parkinsonism
1992
Vitamin C Deficiency Facilitates 5‐S‐Cysteinyldopamine Formation in Guinea Pig Striatum
1991 StandoutNobel
Microglia as a Potential Bridge between the Amyloid β‐Peptide and Tau
2004
Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study
1994
A Role for 12-lipoxygenase in Nerve Cell Death Caused by Glutathione Depletion
1997
Glutathione decreases in dopaminergic PC12 cells interfere
with the ubiquitin protein degradation pathway: relevance
for Parkinson's disease?
2002
Reactive Oxygen Species and the Central Nervous System
1992 Standout
Cloning and characterization of a mammalian proton-coupled metal-ion transporter
1997 StandoutNature
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
1989
T1ρ and T2ρ MRI in the evaluation of Parkinson’s disease
2010
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
2007 Standout
Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?
1989
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Treatment of extrapyramidal side effects with terguride
1992
Dose- and time-dependent α-synuclein aggregation induced by ferric iron in SK-N-SH cells
2010
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes
2001
Effect of acidosis and anoxia on iron delocalization from brain homogenates
1992
Oxidative Stress Hypothesis in Alzheimer's Disease
1997 Standout
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
2003
Differential neurotoxicity induced by l-DOPA and dopamine in cultured striatal neurons
1996
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
1998 StandoutNature
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
2002 Standout
Brain iron and ferritin in Parkinson's and Alzheimer's diseases
1990
A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome
2001
Glutathione Depletion in PC12 Results in Selective Inhibition of Mitochondrial Complex I Activity
2000
Neurotrophic Effects of l ‐DOPA in Postnatal Midbrain Dopamine Neuron/Cortical Astrocyte Cocultures
1997
5‐S‐Cysteinyl‐conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase‐3 activity in neurons
2002
Decreased Ferritin Levels in Brain in Parkinson's Disease
1990
Association between mitochondrial dysfunction and severity and outcome of septic shock
2002
Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease
1989
The Expression of Key Oxidative Stress-Handling Genes in Different Brain Regions in Alzheimer's Disease
1998
An Improved HPLC‐Electrochemical Detection Method for Measuring Brain Levels of 5‐S‐Cysteinyldopamine, 5‐S‐Cysteinyl‐3,4‐Dihydroxyphenylalanine, and 5‐S‐Cysteinyl‐3,4‐Dihydroxyphenylacetic Acid
1990 StandoutNobel
Amyloid‐β‐induced toxicity of primary neurons is dependent upon differentiation‐associated increases in tau and cyclin‐dependent kinase 5 expression
2003
A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains
1992
The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra
1989 StandoutNobel
Cerebrospinal fluid ferritin levels of patients with Parkinson's disease, Alzheimer's disease, and multiple system atrophy
1994
Aging, energy, and oxidative stress in neurodegenerative diseases
1995
Phenolics as potential antioxidant therapeutic agents: Mechanism and actions
2005 Standout
Superoxide Dismutase/Catalase Mimetics Are Neuroprotective against Selective Paraquat-mediated Dopaminergic Neuron Death in the Substantial Nigra
2005
Partial dopamine receptor agonists reverse behavioral, biochemical and neuroendocrine effects of neuroleptics in the rat: Potential treatment of extrapyramidal side effects
1993 StandoutNobel
Dopamine toxicity in neuroblastoma cells: role of glutathione depletion by l-BSO and apoptosis
2000
Oxygen Free Radicals and Brain Dysfunction
1991
A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1
2011 StandoutNatureNobel
Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease
1994
Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray Microanalysis
1992
PI3K signaling of autophagy is required for starvation tolerance and virulenceof Cryptococcus neoformans
2008 StandoutNobel
Nrf2-induced antioxidant protection: A promising target to counteract ROS-mediated damage in neurodegenerative disease?
2008
Blood donations, iron stores, and risk of Parkinson's disease
2006
Iron trafficking inside the brain
2007
Phospholipid peroxidation induced by the catechol-Fe3+(Cu2+) complex: A possible mechanism of nigrostriatal cell damage
1990
Global cancer statistics
2011 Standout
Intranigral Iron Injection Induces Behavioral and Biochemical “Parkinsonism” in Rats
1991
Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease
1997
Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease
1997
Higher iron in the red nucleus marks Parkinson's dyskinesia
2012
Contribution of beverages to the intake of lipophilic and hydrophilic antioxidants in the Spanish diet
2003
Nitric oxide synthase and neuronal vulnerability in parkinson's disease
1996
Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study
1992
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
2012 Standout
Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental lewy body disease
1992
Flavonoid-induced glutathione depletion: Potential implications for cancer treatment
2006
An immunohistochemical study on manganese superoxide dismutase in Parkinson's disease
1997
Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability
2006
Oxidative stress in Parkinson's disease
2003 Standout
Increased monoamine oxidase b activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography
1994
Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein
2002
Complex I, Iron, and ferritin in Parkinson's disease substantia nigra
1994
Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans
2002
Sequestration of iron by Lewy bodies in Parkinson's disease
2000
Induction of DNA damage, alteration of DNA repair and transcriptional activation by stress hormones
2007
Terguride in Parkinsonism a multicenter trial
1988
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke?
1989
Imaging iron stores in the brain using magnetic resonance imaging
2005
Oxidative stress as a cause of Parkinson's disease
1991
Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product
1999
The influence of pH on antioxidant properties and the mechanism of antioxidant action of hydroxyflavones
2001
Cellular management of iron in the brain
1995
Peripheral iron metabolism in patients with Parkinson's disease
1994
Serum Antioxidant Capacity Is Increased by Consumption of Strawberries, Spinach, Red Wine or Vitamin C in Elderly Women
1998
Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure
2004
Role of mitochondria in the etiology and pathogenesis of Parkinson's disease
1995
The Role of Iron in Neurodegeneration
1999
Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X‐Ray Microanalysis
1991
Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts.
1994 StandoutNobel
Involvement of Endoplasmic Reticulum Stress on the Cell Death Induced by 6-Hydroxydopamine in Human Neuroblastoma SH-SY5Y Cells
2006
Oxidative metabolites of 5-S-cysteinyldopamine inhibit the α-ketoglutarate dehydrogenase complex: possible relevance to the pathogenesis of Parkinson's disease
2000
The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
1992
Postmortem Stability of Monoamines, Their Metabolites, and Receptor Binding in Rat Brain Regibns
1994
Methamphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells
2003
Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson’s disease? Implications from MRI and TCS studies
2012
In Vivo Autoxidation of Dopamine in Guinea Pig Striatum Increases with Age
1990 StandoutNobel
Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease
2002
Reactive oxygen species have a causal role in multiple forms of insulin resistance
2006 StandoutNature
Lack of up‐regulation of ferritin is associated with sustained iron regulatory protein‐1 binding activity in the substantia nigra of patients with Parkinson's disease
2002
Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention
2007
Mass Spectrometric Quantification of 3-Nitrotyrosine, ortho-Tyrosine, and o,o′-Dityrosine in Brain Tissue of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated Mice, a Model of Oxidative Stress in Parkinson's Disease
1999
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
Interaction of neuromelanin and iron in substantia nigra and other areas of human brain
1996
The Antioxidant Activity of Regularly Consumed Fruit and Vegetables Reflects their Phenolic and Vitamin C Composition
2002
Biochemistry of Parkinson's disease with special reference to the dopaminergic systems
1994
Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease
1997
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
1994
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Nitric oxide-mediated mitochondrial damage: A potential neuroprotective role for glutathione
1996
Quantitative structure–activity relationships in prooxidant cytotoxicity of polyphenols: Role of potential of phenoxyl radical/phenol redox couple
2005
Endogenous Activation of mGlu5 Metabotropic Glutamate Receptors Contributes to the Development of Nigro-Striatal Damage Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in Mice
2004
Iron in the basal ganglia in Parkinson's disease
1999
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Oxygen free radicals and Parkinson's disease
1991
Cellular iron transport
2009
The importance of glutathione in human disease
2003 Standout
Role of dietary iron restriction in a mouse model of Parkinson's disease
2004
Brain ferritin iron may influence age- and gender-related risks of neurodegeneration
2006
Chronic high dose L-DOPA alone or in combination with the COMT inhibitor entacapone does not increase oxidative damage or impair the function of the nigro-striatal pathway in normal cynomologus monkeys
2002
Oxidative stress and antioxidant therapy in Parkinson's disease
1996
In vivo detection of iron and neuromelanin by transcranial sonography: A new approach for early detection of substantia nigra damage
2005
Iron‐sulfur enzyme mediated mitochondrial superoxide toxicity in experimental Parkinson's disease
2004
Hypoxia-inducible Factor Prolyl 4-Hydroxylase Inhibition
2005
Metal-triggered Structural Transformations, Aggregation, and Fibrillation of Human α-Synuclein
2001
Glutathione‐related enzymes in brain in Parkinson's disease
1994
Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study
1994
Biological effects of essential oils – A review
2007 Standout
Dopa and dopamine cause cultured neuronal death in the presence of iron
1991
Neuromelanin associated redox‐active iron is increased in the substantia nigra of patients with Parkinson's disease
2003
Toxic and Protective Effects of l ‐DOPA on Mesencephalic Cell Cultures
1993
Mitochondria-targeted antioxidants for treatment of Parkinson's disease: Preclinical and clinical outcomes
2013
The immunopathogenesis of sepsis
2002 StandoutNature
Functional roles of transferrin in the brain
2011
Oxygen Radical Absorbance Capacity of the Phenolic Compounds in Plant Extracts Fractionated by High-Performance Liquid Chromatography
2001
Green tea drinking, high tea temperature and esophageal cancer in high‐ and low‐risk areas of Jiangsu Province, China: A population‐based case–control study
2008
Modeling neurodevelopmental disorder-associated humanAGO1mutations inCaenorhabditis elegansArgonautealg-1
2024 StandoutNobel
Evidence of neuronal oxidative damage in Alzheimer's disease.
1996
Levodopa-Induced Neurotoxicity
1997
Effect of High-Oxygen Atmospheres on Blueberry Phenolics, Anthocyanins, and Antioxidant Capacity
2003
Further Insights into the Influence of l -Cysteine on the Oxidation Chemistry of Dopamine: Reaction Pathways of Potential Relevance to Parkinson's Disease
1996
NMDA But Not Non-NMDA Excitotoxicity is Mediated by Poly(ADP-Ribose) Polymerase
2000
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Brain trace elements and aging
1999
The problems of using one-dimensional methods to evaluate multifunctional food and biological antioxidants
2000
The determination of iron and other metals by INAA in Cortex, Cerebellum and Putamen of human brain and in their neuromelanins
2001
Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling
2011 Standout
Gold nanoparticles mediate the assembly of manganese dioxide nanoparticles for H2O2 amperometric sensing
2010
Antioxidant Activity of Pomegranate Juice and Its Relationship with Phenolic Composition and Processing
2000 Standout
Oxygen Radical Absorbing Capacity of Anthocyanins
1997
Free radicals, antioxidants, and human disease: where are we now?
1992 Standout
Decreased iron levels in the temporal cortex in postmortem human brains with Parkinson disease
2013
Standardized Methods for the Determination of Antioxidant Capacity and Phenolics in Foods and Dietary Supplements
2005 Standout
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging
2004
Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.
1995
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
1996
A Macrophage−Nanozyme Delivery System for Parkinson's Disease
2007
Role of Brain Iron Accumulation in Cognitive Dysfunction: Evidence from Animal Models and Human Studies
2013
Oxidative stress and iron imbalance in Alzheimer disease: How rust became the fuss!
2006
Antioxidant Activity and Total Phenolics in Selected Fruits, Vegetables, and Grain Products
1998 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease
2008
Review: Methods Used to Evaluate the Free Radical Scavenging Activity in Foods and Biological Systems
2002
Anthocyanins, Phenolics, and Antioxidant Capacity in Diverse Small Fruits: Vaccinium,Rubus, andRibes
2001 Standout
Antioxidant Activity and Phenolic Content of Oregon Caneberries
2002
Spermidine in health and disease
2018 StandoutScience
Luminescent Functional Metal–Organic Frameworks
2011 Standout
Serum iron and neuroleptic malignant syndrome
1991
Analysis of Antioxidant Activities of Common Vegetables Employing Oxygen Radical Absorbance Capacity (ORAC) and Ferric Reducing Antioxidant Power (FRAP) Assays: A Comparative Study
2002
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
1999
Catecholamine Oxidative Products, but Not Melanin, Are Produced byCryptococcus neoformansduring Neuropathogenesis in Mice
1999
Screening Methods To Measure Antioxidant Activity of Sorghum (Sorghum bicolor) and Sorghum Products
2003
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Assays for Hydrophilic and Lipophilic Antioxidant Capacity (oxygen radical absorbance capacity (ORACFL)) of Plasma and Other Biological and Food Samples
2003
Blood-Borne Macrophage–Neural Cell Interactions Hitchhike on Endosome Networks for Cell-Based Nanozyme Brain Delivery
2012
Lipophilic and Hydrophilic Antioxidant Capacities of Common Foods in the United States
2004
MRI of the human brain at 130 microtesla
2013 StandoutNobel
Brain iron in the ferrocene-loaded rat: Its chelation and influence on dopamine metabolism
1995
Normal Mitochondrial Genome in Brain from Patients with Parkinson's Disease and Complex I Defect
1990
Comparison of different analytical methods for assessing total antioxidant capacity of human serum
1998
Rapid metabolic evolution in human prefrontal cortex
2011 StandoutNobel
Exosomes as drug delivery vehicles for Parkinson's disease therapy
2015 Standout
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
2007 StandoutScience
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
Global cancer statistics, 2012
2015 Standout
Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease
1993
Nitric oxide prevents axonal degeneration by inducing HIF-1–dependent expression of erythropoietin
2011 StandoutNobel
Flavonol glycosides and antioxidant capacity of various blackberry and blueberry genotypes determined by high‐performance liquid chromatography/mass spectrometry
2005
Copper, iron, and zinc ions homeostasis and their role in neurodegenerative disorders (metal uptake, transport, distribution and regulation)
2009
Autophagy as a Regulated Pathway of Cellular Degradation
2000 StandoutScience
Dopamine-Dependent Iron Toxicity in Cells Derived from Rat Hypothalamus
2005
Antioxidant and Antiradical Activities of Flavonoids
2001
Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress
2020
Oxidative stress in neurodegeneration: cause or consequence?
2004 Standout
Works of E. Sofić being referenced
Physical stress-induced secretion of adrenal and pituitary hormones in patients with atopic eczema compared with normal controls
2009
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
1988
Antioxidant and Prooxidant Behavior of Flavonoids: Structure-Activity Relationships
1997 Standout
Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains
1989
Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains
1991
Antioxidant capacity in postmortem brain tissues of Parkinson’s and Alzheimer’s diseases
2006
Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease
1992
Brain quinolinic acid in Alzheimer's dementia
1989
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease
1992
Decreased Catalase Activity but Unchanged Superoxide Dismutase Activity in Brains of Patients with Dementia of Alzheimer Type
1995
The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primates
1993
Amperometric determination of bonded glucose with an MnO2 and glucose oxidase bulk-modified screen-printed electrode using flow-injection analysis
2004
Terguride: partial dopamine agonist in the treatment of Parkinson's disease.
1987
Antioxidant Capacity of Tea and Common Vegetables
1996 Standout
Antioxidant Capacity As Influenced by Total Phenolic and Anthocyanin Content, Maturity, and Variety ofVacciniumSpecies
1998 Standout
High-Performance Liquid Chromatography Coupled with Coulometric Array Detection of Electroactive Components in Fruits and Vegetables: Relationship to Oxygen Radical Absorbance Capacity
1997
Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenyl.
1987
Biochemical fundamentals of Parkinson's disease.
1988